ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $1.11M invested in Entero Therapeutics in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$153K
2
+$86.8K

Top Sellers

1
-$130K
2
-$57K
3
-$39K
4
Squarepoint
Squarepoint
New York
-$36K
5
AAP
Ardsley Advisory Partners
Connecticut
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$521K
2
$153K
3
$127K
4
$57K
5
$49K
6
$40K
7
$36K
8
$30K
9
$28K
10
$21K
11
$20K
12
$14K
13
$11K
14
$4K
15
$1K
16
$1K
17
–
18
–
19
–
20
–